[{"AccountsPayableCurrent_0_Q2_USD":21459000000.0,"GainLossRelatedToLitigationSettlement_1_Q2_USD":-21000000.0,"GainLossRelatedToLitigationSettlement_2_Q2_USD":-5694000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-1000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-18000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":3167000000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":21000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":41000000.0,"StockholdersEquityOther_1_Q2_USD":1000000.0,"Dividends_2_Q2_USD":284000000.0,"StockholdersEquityOther_2_Q2_USD":1000000.0,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":-15.99,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q2_USD":0.75,"IncomeLossFromContinuingOperationsPerDilutedShare_2_Q2_USD":-15.99,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.4811,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.9622,"ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_1_Q2_USD":0.0,"DeferredTaxAndOtherLiabilitiesNoncurrent_0_Q2_USD":8408000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q2_USD":3000000.0,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":0.75,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2_Q2_USD":7000000.0,"Dividends_1_Q2_USD":143000000.0,"LossOnSaleOfInvestments_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":218000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-4726000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-2000000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-24000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-2000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-24000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":279000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-5065000000.0,"OtherAssetsCurrent_0_Q2_USD":1998000000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":464000000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":11000000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":287000000.0,"TreasuryStockShares_0_Q2_shares":35000000.0,"TreasuryStockValue_0_Q2_USD":2099000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":2000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":0.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":218000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-4725000000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":793000000.0,"FinanceLeaseLiability_0_Q2_USD":15000000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":4000000.0,"FinanceLeasePrincipalPayments_1_Q2_USD":3000000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.029,"OtherBorrowings_0_Q2_USD":698000000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_1_Q2_USD":-1000000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_2_Q2_USD":-6000000.0,"PaymentsForRestructuring_2_Q2_USD":24000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":0.0,"ProceedsFromRepaymentsOfShortTermDebt_2_Q2_USD":681000000.0,"ReceivablesNetCurrent_0_Q2_USD":8280000000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":404000000.0,"RestructuringCharges_1_Q2_USD":56000000.0,"RestructuringCosts_2_Q2_USD":64000000.0,"RestructuringReserve_0_Q2_USD":112000000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q2_USD":54000000.0,"SeveranceCosts1_2_Q2_USD":62000000.0,"SeveranceCosts1_1_Q2_USD":42000000.0,"UnrecognizedTaxBenefits_0_Q2_USD":940000000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":132000000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q2_USD":791000000.0,"RestructuringCharges_2_Q2_USD":86000000.0,"OperatingLeasePayments_1_Q2_USD":61000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":324000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":102000000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":14000000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q2_USD":4000000.0,"FinanceLeaseRightOfUseAssetAmortization_2_Q2_USD":8000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":258000000.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_1_Q2_USD":-7000000.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_2_Q2_USD":-8000000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-17000000.0,"GoodwillTransfers_2_Q2_USD":-5000000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":-5128000000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":22000000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":5848000000.0,"LeaseCost_1_Q2_USD":45000000.0,"LeaseCost_2_Q2_USD":81000000.0,"LongTermDebtAndCapitalLeaseObligationsCurrent_0_Q2_USD":1192000000.0,"NumberOfOperatingSegments_2_Q2_segment":2.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"OperatingLeaseCost_1_Q2_USD":30000000.0,"OperatingLeaseCost_2_Q2_USD":61000000.0,"OperatingLeaseLiability_0_Q2_USD":426000000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":47000000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2239000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":294000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":292000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":149000000.0,"ProfitLoss_1_Q2_USD":220000000.0,"ProfitLoss_2_Q2_USD":-4701000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2301000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":449000000.0,"Revenues_1_Q2_USD":39735000000.0,"Revenues_2_Q2_USD":77076000000.0,"StockholdersEquity_0_Q2_USD":999000000.0,"NetIncomeLoss_2_Q2_USD":-4702000000.0,"CommonStockSharesAuthorized_0_Q2_shares":755000000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":11523000000.0,"InterestExpense_1_Q2_USD":63000000.0,"InterestExpense_2_Q2_USD":129000000.0,"OperatingIncomeLoss_1_Q2_USD":334000000.0,"OperatingIncomeLoss_2_Q2_USD":-4930000000.0,"PaymentsForRepurchaseOfCommonStock_1_Q2_USD":0.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":350000000.0,"PreferredStockSharesAuthorized_0_Q2_shares":500000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":2681000000.0,"NetIncomeLoss_1_Q2_USD":220000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":44000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-151000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-103000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":6000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4000000.0,"Assets_0_Q2_USD":41042000000.0,"AssetsCurrent_0_Q2_USD":25736000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1659000000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":-872000000.0,"CommonStockSharesIssued_0_Q2_shares":327000000.0,"CommonStockValue_0_Q2_USD":2752000000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":-5000000.0,"GrossProfit_1_Q2_USD":1714000000.0,"GrossProfit_2_Q2_USD":3393000000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":59000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-364000000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-77000000.0,"InventoryNet_0_Q2_USD":13799000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":41042000000.0,"LiabilitiesCurrent_0_Q2_USD":24890000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-760000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"VariableLeaseCost_1_Q2_USD":11000000.0,"PreferredStockValue_0_Q2_USD":0.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":2270000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":1002000000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":38021000000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":73683000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":328000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":358000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":408000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":442000000.0,"Goodwill_0_Q2_USD":8356000000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"MinorityInterest_0_Q2_USD":3000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":1000000.0,"OtherAssetsNoncurrent_0_Q2_USD":1482000000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1_Q2_USD":17000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":6000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":63.43,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":0.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":23000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":30000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":63.52,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":6000000.0,"ShareBasedCompensation_2_Q2_USD":41000000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":294000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":294000000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":127000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":256000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.21,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.072,"IncreaseDecreaseInInventories_2_Q2_USD":991000000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":-121000000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q2_USD":6742000000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":-4000000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-4000000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":5826000000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":3145000000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":12000000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-2000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":1163000000.0,"VariableLeaseCost_2_Q2_USD":12000000.0,"Ticker":"CAH","CIK":"721371","name":"CARDINAL HEALTH INC","OfficialName":"Cardinal Health Inc. Common Stock","form":"10-Q","period":"20191231","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17377290506.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20200206"}]